Biography/Journey of Subhag HealthTech
Journey of Subhag HealthTech
Subhag HealthTech is a pioneering startup that was founded
by three engineers: Vikram Rajput, Soham Sahu, and Chandan Prasad. The company
was created with a mission to solve one of society's most pressing issues:
infertility. With their combined expertise in engineering and innovation, they
set out to develop accessible, affordable, and effective fertility solutions
for couples struggling to conceive. Their goal was clear — no couple should
remain childless because of the unavailability of infertility treatments.
An Innovative Solution for Infertility
Subhag HealthTech introduced a revolutionary product called
V-Conceive, a home-based Intrauterine Insemination (IUI) kit. This device
allows couples to perform IUI procedures privately and conveniently at home,
bypassing the need for expensive and invasive clinic visits. The company's IUI
kit, along with other devices like AndroWash™, has quickly gained attention for
making fertility treatment more accessible and less stressful for individuals
struggling with infertility.
The Vision Behind Subhag HealthTech
The founders of Subhag realized that infertility is a
growing problem, affecting one in every seven couples worldwide. Many people
suffering from infertility face emotional and social distress, often isolating
themselves due to the stigma. While In vitro fertilization (IVF) is a
well-known solution, its high cost, inaccessibility, and lack of privacy make
it a difficult option for many. Subhag's vision was to create an affordable,
accessible, and private alternative that could be used at home, eliminating many
of these barriers.
The Subhag IUI Kit: A Game Changer
Subhag's flagship product, the IUI kit, enables couples to
perform Intrauterine Insemination at home. The kit includes an ovulation strip
to help track the right time for insemination, V-Conceive soft cups for
performing the insemination, and AndroWash for sperm preparation. This
easy-to-use, patented solution allows couples to experience fertility treatment
in the comfort of their own homes. The company's products have already been
prescribed by over 20 hospitals and 300 clinics, and they boast a promising
success rate of 16% on the first attempt.
Affordable and Accessible Fertility Solutions
One of Subhag's main goals is to make fertility treatments
much more affordable than traditional IVF or IUI procedures. The company's IUI
kit is priced significantly lower than the alternatives available in clinics,
making it an attractive option for couples who need a more budget-friendly
solution. The V-Conceive kit, for instance, is sold at a price of around ₹5000,
while its actual market price is ₹8000. This pricing structure helps ensure
that fertility treatments are within reach for a larger number of people.
Rapid Growth and Sales Expansion
Since its inception, Subhag HealthTech has shown impressive
growth in sales. In the first year, the company sold 3500 units of its
V-Conceive kit and 20 units of AndroWash. Despite a brief pause in sales due to
regulatory changes in September 2022, Subhag continues to show strong financial
performance. In the 2020-21 fiscal year, the company generated ₹37 lakh in
revenue, which increased to ₹52 lakh the following year. The company’s monthly
sales run-rate averages ₹5 lakh, suggesting steady growth in demand for its
innovative fertility solutions.
Regulatory Hurdles and Setbacks
Despite the company's promising growth, Subhag has faced
challenges, particularly with regulatory changes that caused a temporary halt
in sales. However, these setbacks have not stopped the company from continuing
its mission. The founders are optimistic about overcoming these hurdles and are
actively working on obtaining the necessary approvals to resume sales. With the
backing of investors and a strong product line, Subhag is poised to continue
growing in the competitive health-tech sector.
Shark Tank India: A Major Milestone
Subhag HealthTech's journey took a significant turn when the
company appeared on Shark Tank India, a popular television show where
entrepreneurs pitch their ideas to a panel of investors. Subhag's pitch was for
₹50 lakh in exchange for 1% equity, valuing the company at ₹50 crore. After
some negotiation, the startup received offers from multiple sharks, including
Namita Thapar and Vineeta Singh. In the end, Subhag accepted Namita’s offer:
₹20 lakh for 1% equity, plus ₹30 lakh in debt at 10% interest.
Strategic Investment for Growth
The deal with Namita Thapar on Shark Tank India was a major
breakthrough for Subhag. Not only did the company secure much-needed funding,
but it also gained a strategic partner who could help navigate the complex
healthcare landscape. The debt funding, combined with equity investment,
provided the company with the necessary capital to expand its product line,
scale its operations, and meet the increasing demand for affordable fertility
solutions.
Subhag’s Patent Portfolio: A Strong Competitive Moat
One of the key factors that sets Subhag apart from its
competitors is its strong intellectual property portfolio. The company has
registered five patents and three trademarks for its products, which include
the V-Conceive IUI kit and AndroWash sperm-washing device. These patents
provide Subhag with a significant competitive advantage, allowing the company
to protect its innovations in a multi-billion-dollar medical device market and
establish a strong moat around its products.
Expanding the Product Line
Subhag's vision extends beyond its current product
offerings. The company is focused on continuously improving and expanding its
product line to meet the evolving needs of couples seeking fertility solutions.
The founders plan to develop new products that will further improve the chances
of conception, as well as extend their reach to more international markets.
Subhag's ultimate goal is to become a leading player in the fertility solutions
industry, offering a range of affordable and effective products to couples
worldwide.
Biography/Journey of Subhag HealthTech/age/net worth/investor/stratup/shark tank/ infertility treatments/Subhag HealthTech/Vikram Rajput, Soham Sahu
Founders’ Journey: A Story of Innovation and Persistence
The founders of Subhag, Vikram Rajput, Soham Sahu, and
Chandan Prasad, are all IIT graduates with diverse expertise in mechanical
engineering, production management, and supply chain. Their combined experience
has been instrumental in the development of Subhag's innovative products.
Vikram Rajput, in particular, has a strong background in R&D, having worked
with companies like Tata Motors and GE, which has contributed to the success of
Subhag’s product development and research efforts.
A Deep Commitment to Helping Others
For Vikram Rajput, the creation of Subhag HealthTech is more
than just a business venture; it’s a deeply personal mission to help couples
struggling with infertility. His vision is to make infertility treatments
affordable and accessible for everyone, irrespective of their financial
background. By offering at-home solutions like the Subhag IUI kit, Vikram hopes
to make a meaningful difference in the lives of couples who would otherwise not
have access to fertility treatments.
The Global Potential of Subhag
While Subhag is currently focused on the Indian market, the
founders have bigger plans in mind. They are aiming to expand globally,
particularly to markets where infertility treatment options are expensive and
limited. With pre-bookings in the United States, Subhag is already making
strides toward international expansion. The company is confident that its
innovative, affordable solutions will resonate with couples around the world,
helping them achieve their dreams of starting a family.
Future Plans for Subhag HealthTech
Looking ahead, Subhag HealthTech has ambitious plans to grow
and diversify its offerings. The company aims to offer a comprehensive suite of
fertility solutions, including additional at-home devices, treatment options,
and ongoing support for couples. Subhag also plans to expand its research and
development efforts to stay at the forefront of medical technology, ensuring
that its products continue to meet the highest standards of effectiveness and
safety.
A Bright Future for Subhag HealthTech
Despite facing some regulatory hurdles and challenges along
the way, Subhag HealthTech has proven its resilience and ability to adapt. With
a strong product line, growing sales, and a solid team of founders, the company
is well-positioned to succeed in the competitive fertility industry. With the
support of investors like Namita Thapar, Subhag is ready to scale its
operations and make a lasting impact on the lives of couples struggling with
infertility. The future looks bright for Subhag HealthTech, as it continues to
revolutionize the way infertility is treated worldwide.
A timeline for the story of Subhag HealthTech with short
explanations:
2019 – Subhag HealthTech is founded by Vikram Rajput, Soham
Sahu, and Chandan Prasad with a mission to make infertility treatments
accessible and affordable.
2020 – Launch of the V-Conceive IUI kit, a home-based
fertility solution, making intrauterine insemination (IUI) accessible and
private for couples.
2020-2021 – Subhag sells 3500 V-Conceive units and 20
AndroWash devices in its first year, generating ₹37 lakh in revenue.
September 2022 – Regulatory changes cause a temporary halt
in sales, but Subhag works towards obtaining necessary approvals.
2022-2023 – Subhag’s sales grow to ₹52 lakh, with a monthly
sales run-rate of ₹5 lakh despite regulatory challenges.
2022 – Subhag appears on Shark Tank India and secures a deal
with investor Namita Thapar: ₹20 lakh for 1% equity plus ₹30 lakh in debt.
2023 – Subhag registers five patents and three trademarks,
securing its intellectual property and strengthening its competitive edge.
2023 – Plans to expand product offerings and enter
international markets, with pre-bookings in the United States.
2024 – Expansion of product line to include more fertility
solutions and continued R&D for future product innovations.
Future – Subhag aims to be a global leader in affordable
fertility solutions, improving accessibility for couples worldwide.
